CRISPR patent “case of the year” hearing is a must-watch – and not just for the life sciences
Reset password
Register to access two of our subscriber only articles per month.
Register
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Subscribe
Author | Life sciences reporter
[email protected]
@IAM_magazine More IBM patents for WiLAN - not clear how many yet but keeping an eye on assignment records https://t.co/IebJzLnzNO Read more
@IAM_magazine Acacia's portfolio of life sciences assets expands with stake in AI medtech business https://t.co/d3OoC0tMtO https://t.co/kHZ48Hin1N Read more
@IAM_magazine RT @jwschindler: Conversant had 5 days to appeal China's first ever anti-suit injunction - I am told that SPC has now heard and rejected it… Read more
@IAM_magazine China has released long-awaited antitrust guidelines on IP issues including patent pools and SEP injunctions. Read… https://t.co/90Fz0xDTz8 Read more
